These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 127123)

  • 1. Fibroblasts in Huntington's disease.
    Goetz I; Roberts E; Comings DE
    N Engl J Med; 1975 Dec; 293(24):1225-7. PubMed ID: 127123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities in growth of skin fibroblasts of patients with Huntington's disease.
    Barkley DS; Hardiwidjaja S; Menkes JH
    Ann Neurol; 1977 May; 1(5):426-30. PubMed ID: 152598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytoskeleton of cultured skin fibroblasts from patients with Huntington's chorea.
    Meek WD
    J Am Osteopath Assoc; 1990 Mar; 90(3):241-53. PubMed ID: 2138600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actin filaments in human skin fibroblasts are similar in normal persons and patients with Huntington's disease.
    Geary LE; Lazarides E; Goetz I; Roberts E
    Ann Neurol; 1978 Dec; 4(6):554-6. PubMed ID: 154310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntington's disease--growth of fibroblast cultures in lipid-deficient medium: a preliminary report.
    Menkes JH; Hanoch A
    Ann Neurol; 1977 May; 1(5):423-5. PubMed ID: 152597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.
    Thu DC; Oorschot DE; Tippett LJ; Nana AL; Hogg VM; Synek BJ; Luthi-Carter R; Waldvogel HJ; Faull RL
    Brain; 2010 Apr; 133(Pt 4):1094-110. PubMed ID: 20375136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin fibroblasts in Huntington's disease.
    Leonardi A; De Martini IS; Perdelli F; Mancardi GL; Salvarani S; Bugiani O
    N Engl J Med; 1978 Mar; 298(11):632. PubMed ID: 146827
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington's disease human brain.
    Curtis MA; Faull RL; Glass M
    J Chem Neuroanat; 2006 Apr; 31(3):210-5. PubMed ID: 16533591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast cultures in Huntington's disease.
    Menkes JH; Stein N
    N Engl J Med; 1973 Apr; 288(16):856-7. PubMed ID: 4266468
    [No Abstract]   [Full Text] [Related]  

  • 13. Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease.
    Hennenlotter A; Schroeder U; Erhard P; Haslinger B; Stahl R; Weindl A; von Einsiedel HG; Lange KW; Ceballos-Baumann AO
    Brain; 2004 Jun; 127(Pt 6):1446-53. PubMed ID: 15090475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic study of red cell osmotic fragility in Huntington's disease.
    McCormack MK; Lazzarini A; Toke D; Lepore F
    Am J Med Genet; 1984 May; 18(1):5-11. PubMed ID: 6234801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal neural grafting improves cortical metabolism in Huntington's disease patients.
    Gaura V; Bachoud-Lévi AC; Ribeiro MJ; Nguyen JP; Frouin V; Baudic S; Brugières P; Mangin JF; Boissé MF; Palfi S; Cesaro P; Samson Y; Hantraye P; Peschanski M; Remy P
    Brain; 2004 Jan; 127(Pt 1):65-72. PubMed ID: 14607797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients.
    Richfield EK; Maguire-Zeiss KA; Cox C; Gilmore J; Voorn P
    Ann Neurol; 1995 Mar; 37(3):335-43. PubMed ID: 7695232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ribosomal subunit proteins from normal human and Huntington's disease skin fibroblasts.
    Prashad N; Rosenberg RN
    Ann Neurol; 1977 May; 1(5):475-7. PubMed ID: 152599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.
    Richfield EK; Herkenham M
    Ann Neurol; 1994 Oct; 36(4):577-84. PubMed ID: 7944290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's disease: changes in tachykinin content in postmortem brains.
    Arai H; Emson PC; Carrasco LH
    Ann Neurol; 1987 Nov; 22(5):587-94. PubMed ID: 2447825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.